The diverse biologic effects of retinoic acid (RA) are thought to be mediated through specific RA receptors (RARs). RA induces the granulocytic differentiation of leukemia cells in patients with acute promyelocytic leukemia (APL). Most RA-sensitive APL samples harbor a specific 15:17 chromosome translocation, which involves the RAR-alpha locus and leads to an aberrant RAR-alpha fusion transcript (designated PML-RAR-alpha). The pathophysiologic consequences of the generation of this aberrant PML-RAR-alpha fusion transcript and its relationship to leukemogenesis are presently unclear. It is also unknown what role, if any, RA might play in regulating normal hematopoiesis. This proposal plans to approach these questions by utilizing retroviral-mediated gene transduction to transfer aberrant RA receptor constructs into hematopoietic cell lines and normal hematopoietic stem cells. The specific questions to be addressed include the following:
Specific Aim I) How does the expression of the aberrant PML-RAR-alpha fusion gene relate to the pathogenesis of APL? To explore the pathophysiologic consequences of the generation of the PML-RAR-alpha fusion gene, we will utilize retrovirus-mediated gene transduction to express this fusion gene in both RA-sensitive and RA- resistant hemopoietic cell lines and compare the differentiation of the uninfected vs. retrovirus-infected cells in response to RA. We will also infect murine hemopoietic stem cells with a retroviral vector harboring the PML-RAR-alpha fusion gene to study the leukemogenic potential of this aberrant RA receptor in vivo.
Specific Aim II) What roles do RA and RA receptors (RAR-alpha) play in regulating normal hematopoiesis? Several lines of indirect evidence suggest that RA and the RA receptor (RAR-alpha) may be involved in regulating normal hematopoiesis. To directly approach this question we will determine the effect on hematopoietic differentiation of introducing a mutant """"""""dominant negative"""""""" RAR-alpha into a hematopoietic cell line that mimics several aspects of normal hematopoiesis as well as into normal murine hematopoietic stem cells in vivo. Although our proposed studies are confined to hematopoietic cells, they may eventually provide insight into the role normal or abnormal RA receptors might play in the development of other human malignancies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA058292-01
Application #
3202440
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1993-01-01
Project End
1995-12-31
Budget Start
1993-01-01
Budget End
1993-12-31
Support Year
1
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Si, Jutong; Collins, Steven J (2002) IL-3-induced enhancement of retinoic acid receptor activity is mediated through Stat5, which physically associates with retinoic acid receptors in an IL-3-dependent manner. Blood 100:4401-9
Johnson, Barton S; Mueller, LeMoyne; Si, Jutong et al. (2002) The cytokines IL-3 and GM-CSF regulate the transcriptional activity of retinoic acid receptors in different in vitro models of myeloid differentiation. Blood 99:746-53
Collins, S J; Ulmer, J; Purton, L E et al. (2001) Multipotent hematopoietic cell lines derived from C/EBPalpha(-/-) knockout mice display granulocyte macrophage-colony-stimulating factor, granulocyte- colony-stimulating factor, and retinoic acid-induced granulocytic differentiation. Blood 98:2382-8
Purton, L E; Morris, J C; Bernstein, I D et al. (2001) All-trans retinoic acid facilitates oncoretrovirus-mediated transduction of hematopoietic repopulating stem cells. J Hematother Stem Cell Res 10:815-25
Purton, L E; Bernstein, I D; Collins, S J (2000) All-trans retinoic acid enhances the long-term repopulating activity of cultured hematopoietic stem cells. Blood 95:470-7
Purton, L E; Bernstein, I D; Collins, S J (1999) All-trans retinoic acid delays the differentiation of primitive hematopoietic precursors (lin-c-kit+Sca-1(+)) while enhancing the terminal maturation of committed granulocyte/monocyte progenitors. Blood 94:483-95
Johnson, B S; Chandraratna, R A; Heyman, R A et al. (1999) Retinoid X receptor (RXR) agonist-induced activation of dominant-negative RXR-retinoic acid receptor alpha403 heterodimers is developmentally regulated during myeloid differentiation. Mol Cell Biol 19:3372-82
Filippova, G N; Lindblom, A; Meincke, L J et al. (1998) A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers. Genes Chromosomes Cancer 22:26-36
Scott, L M; Mueller, L; Collins, S J (1996) E3, a hematopoietic-specific transcript directly regulated by the retinoic acid receptor alpha. Blood 88:2517-30
Tsai, S; Bartelmez, S; Sitnicka, E et al. (1994) Lymphohematopoietic progenitors immortalized by a retroviral vector harboring a dominant-negative retinoic acid receptor can recapitulate lymphoid, myeloid, and erythroid development. Genes Dev 8:2831-41

Showing the most recent 10 out of 11 publications